Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

NCT01762410 · clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
60
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision not related to patient safety

Conditions

Interventions

Sponsor

Piramal Enterprises Limited